Export of unapproved drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, second session, on H.R. 3962 and H.R. 3995 ... April 28, 1986.

Show other versions (2)

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment
Language:	English
Published:	Washington : U.S. G.P.O. : For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O., 1986.
Subjects:	Drugs > Law and legislation > United States. Pharmaceutical industry > United States. Foreign trade regulation > United States.
Physical Description:	iii, 108 pages : illustrations ; 24 cm
Format:	Government Document Book

Similar Items

Export of unapproved drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, second session, on H.R. 3962 and H.R. 3995 ... April 28, 1986.
Published: (1986)

Export of unapproved drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, second session, on H.R. 3962 and H.R. 3995 ... April 28, 1986.
Published: (1986)

Access to unapproved drugs : FDA policies on compassionate use and emergency use authorization
by: Thaul, Susan
Published: (2018)

Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010.
Published: (2013)

Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010.
Published: (2012)

Compassionate use and emergency use authorization for unapproved drugs FDA policies and background
Published: (2015)

Promotion of drugs and medical devices for unapproved uses : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, June 11, 1991.
Published: (1992)

Promotion of drugs and medical devices for unapproved uses : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, June 11, 1991.
Published: (1992)

Promotion of drugs and medical devices for unapproved uses : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, June 11, 1991.
Published: (1992)

Drug export reform : hearing before the Committee on Labor and Human Resources, United States Senate, Ninety-ninth Congress, first session, on proposed legislation to amend the Federal Food, Drug, and Cosmetic Act ... June 5, 1985.
Published: (1986)

Drug export reform : hearing before the Committee on Labor and Human Resources, United States Senate, Ninety-ninth Congress, first session, on proposed legislation to amend the Federal Food, Drug, and Cosmetic Act ... June 5, 1985.
Published: (1986)

Drug export reform : hearing before the Committee on Labor and Human Resources, United States Senate, Ninety-ninth Congress, first session, on proposed legislation to amend the Federal Food, Drug, and Cosmetic Act ... June 5, 1985.
Published: (1986)

Prescription drugs : the number, role, and ownership of pharmacy services administrative organizations : report to the Ranking Member, Committee on Energy and Commerce, House of Representatives.
Published: (2013)

Promotion of drugs and medical devices for unapproved uses hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, June 11, 1991.
Published: (1992)

Defining drugs : how government became the arbiter of pharmaceutical fact
by: Parrish, Richard Henry
Published: (2003)

Guideline for submitting supporting documentation in drug applications for the manufacture of drug substances
Published: (1987)

Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session.
Published: (1980)

Drug importation : would the price be right? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the price of drug reimportation, focusing on implications for United States consumers, pricing, research and development, and innovation, February 17, 2005.
Published: (2005)

Drug importation would the price be right? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the price of drug reimportation, focusing on implications for United States consumers, pricing, research and development, and innovation, February 17, 2005.
Published: (2005)

Prescription drugs : strategic framework would promote accountability and enhance efforts to enforce the prohibitions on personal importation : report to congressional requesters.
Published: (2005)

Orphan drug reauthorization hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994.
Published: (1994)

Orphan drug reauthorization : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994.
Published: (1994)

Orphan drug reauthorization : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994.
Published: (1994)

Orphan drugs : medical versus market value
by: Asbury, Carolyn H.
Published: (1985)

Export of unapproved drugs: hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, second session, on H.R. 3962 and H.R. 3995 ... April 28, 1986

Would prescription drug importation reduce U.S. drug spending.
by: Baker, Colin (Colin Sean)
Published: (2007)

Prescription drug pricing in the private sector.
Published: (2007)

Regulation and drug development
by: Wardell, William M.
Published: (1975)

Drug development
Published: (1982)

Preliminary report of the survey on drugs for rare disease
Published: (1982)

Preliminary report of the survey on drugs for rare disease
Published: (1982)

Penalties for illegal activities in the approval of drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, on H.R. 4810 ... June 28, 1990.
Published: (1990)

Penalties for illegal activities in the approval of drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, on H.R. 4810 ... June 28, 1990.
Published: (1990)

Penalties for illegal activities in the approval of drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, on H.R. 4810 ... June 28, 1990.
Published: (1990)

Regulation and drug development
by: Wardell, William M.
Published: (1975)

Seniors' access to affordable prescription drugs models for reform : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, February 16, 2000.
Published: (2000)

Pharmaceutical R&D and the evolving market for prescription drugs.
by: Austin, David
Published: (2009)

Perspectives of drug manufacturers : investigational new drug and new drug applications.
Published: (1990)

Examining drug shortages and recent efforts to address them : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, February 10, 2014.
Published: (2014)

Competitive problems in the drug industry : drug testing : summary and analysis
Published: (1979)